Efficacy of Ipomoea batatas (Caiapo) on Diabetes Control in Type 2 Diabetic Subjects Treated with Diet

Diabetes Care

Volumn 27, Issue 2, 2004, Pages 436-440

  Ludvik, Bernhard ^a,d   Neuffer, Beatrice ^b   Pacini, Giovanni ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b National Research Council ^*  (Switzerland)

^c CNR   (Italy)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

'CAIAPO'; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; IPOMOEA BATATAS EXTRACT; PLACEBO; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIABETES CONTROL; DIABETIC DIET; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MALE; METABOLIC REGULATION; METEORISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; STOMACH PAIN; SWEET POTATO; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IPOMOEA BATATAS; LIPIDS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLACEBOS; POSTPRANDIAL PERIOD;

EID: 0842289944     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.2.436     Document Type: Article

References (19)

1. DeFronzo RA: Lilly lecture 1987: the triumvirate: beta-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37: 667-687, 1988
2. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995
3. Groop LC: Sulfonylureas in NIDDM. Diabetes Care 15:737-754, 1992
4. Bailey CJ: Biguanides and NIDDM. Diabetes Care 15:755-772, 1992
5. DeFronzo RA: Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 131:281-303, 1999
6. Nolan JJ, Jones NP, Patwardhan R, Deacon LF: Rosiglitazone taken once daily provides effective glycaemic control in patients with type 2 diabetes mellitus. Diabet Med 17:287-294, 2000
7. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL: Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study: the Pioglitazone 001 Study Group. Diabetes Care 23: 1605-1611, 2000
8. Sotaniemi EA, Haapakoski E, Rautio A: Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18: 1373-1375, 1995
9. Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Xu Z: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-1226, 2000
10. Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B, Yamamoto S: Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 26:1714-1718, 2003
11. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS: Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26: 1277-1294, 2003
12. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280: 1569-1575, 1998
13. Angell M, Kassirer JP: Alternative medicine: the risks of untested and unregulated remedies. N Engl J Med 339:839-841, 1998
14. Kusano S, Abe H: Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats. Biol Pharm Bull 23:23-26, 2000
15. Kusano S, Abe H, Tamura H: Isolation of antidiabetic components from white-skinned sweet potato (Ipomoea batatas L.). Biosci Biotechnol Biochem 65:109-114, 2001
16. Ludvik BH, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A, Pacini G: The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study (Letter). Diabetes Care 25:239-240, 2002
17. Holman RR, Cull CA, Turner RC: A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 22:960-964, 1999
18. Saloranta C, Hershon K, Ball M, Dickinson S, Holmes D: Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia. J Endocrinol Metab 87:4171-4176, 2002
19. Ludvik B, Waldhäusl W, Prager R, Kautzky-Willer A, Pacini G: Mode of action of Ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism 52:875-880, 2003